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ABSTRACT
A new diterpenoid, (13S)-9,13-epoxylabda-6(19),15(14)diol dilactone (1), was isolated from Leonotis leonurus and the struc-
ture determined via NMR analysis. The compound causes significant changes in blood pressure of anaesthetized normotensive
rats and exhibits a negative chronotropic effect.
KEYWORDS
Leonotis leonurus, diterpenoid, NMR analysis, chronotropic effect.
1. Introduction
The pharmacological evaluation of plants used in traditional
medicines represents a promising approach to the discovery of
new drugs. However, only a small number of the plants used
extensively in traditional medicine in South Africa have been
fully studied to assess their purported pharmacological effects.1
Leonotis leonurus (Watt 1962) (Laminaceae) is a shrub indigenous
to the southern tip of Africa and traditionally the leaves have
been smoked to relieve epileptic fits, leaf infusions or decoctions
used externally to treat boils, eczema, skin diseases, itching and
muscular cramps, and internally to treat influenza, headaches,
jaundice, bronchitis, coughs and high blood pressure.2–4 Our
particular interest in L. leonurus lies in its cardiovascular effects
and while studies relating to this topic have been undertaken on
crude aqueous and methanol extracts of the plant,5–8 no investi-
gation of the cardiovascular effects of any single pure compound
has been carried out, in spite of the fact that many have been iso-
lated.9–13 All isolated compounds to date have been diterpenoids
and with respect to the cardiovascular system, these types of
compounds have been shown to relax vascular smooth muscles
and decrease heart rate in isolated arteries and anaesthetized
rats respectively.14–20
2. Results and Discussion
Our ongoing investigation into the phytochemistry of L. leonurus
has led to the isolation of a further new diterpenoid (1) from the
methanol extract of the plant. The high-resolution electron
impact mass spectrum (HREIMS) indicated a [M+H]+ ion at m/z
349.2009, which correlates with the molecular formula C20H29O5
(calcd. for C20H29O5 349.2015). From the
1H NMR spectrum
the diastereotopic protons in the δ 1 to 2.5 ppm region and the
doublet of doublets at δ 4.70 ppm indicated that the new
molecule was most likely a diterpenoid similar to those previ-
ously isolated from the plant (see Fig. 1). The 13C NMR spectrum
indicated the presence of 20 unique carbon atoms with the DEPT
spectrum showing there to be three methyl , eight CH2 and three
CH groups. Based on the distinctive chemical shifts of two of the
remaining six quaternary carbons at δ 83.6 and 93.5 ppm the
presence of two-spiro fused five-membered rings was very
likely. In addition, two carbonyl moieties (δ 183.8 and 171.4 ppm)
could be identified. At this point it was ascertained from the
above information that the molecule was similar to a diterpenoid
simply known as compound X, that had previously been iso-
lated from L. leonurus,10,12 and which assisted in the deduction of
the structure of 1 for this new diterpenoid. Using HSQC, HMBC
and COSY NMR spectra it was confirmed that 1 and compound
X are positional isomers of one another with the lactone carbonyl
being at C-14 in 1 rather than at C-15 as in compound X. This is
clear from the presence of the ethano carbons at C-15 and C-16 in
1 (coupling seen in the 1H and COSY NMR spectra) as opposed
to compound X which has two isolated CH2 groups at C-14 and
C-16. The relative stereochemistry of 1 is consistent with that of
other diterpenoids isolated from L. leonurus,9–13 as evidenced
from the scalar couplings measured in the 1H NMR spectrum
and also from correlations observed in the 2D NOESY spectrum
collected (see Fig. 2). This is the first time to our knowledge that
diterpenoid 1 has been isolated from L. leonurus or any other
plant.
Diterpenoid 1 was administered intravenously to anaesthetized
normotensive male Wistar rats in order to evaluate its cardiovas-
cular activity. Results indicate dose-dependent changes in blood
pressure and heart rate (HR) in the rats. Interestingly, on the one
hand, the 0.5, 1.0 and 2.0 mg kg–1 doses produced dose-dependent
decreases in systolic pressure (SP), diastolic pressure (DP) and
mean arterial pressure (MAP), all of which were statistically
significant (Fig. 3). On the other hand, administration of the
higher 3.0, 4.0 and 5.0 mg kg–1 doses produced dose-dependent
increases in SP, DP and MAP which were also statistically signifi-
cant (Fig. 3). All doses induced significant dose-dependent
decreases in HR in the animals (Fig. 4).
The decrease in blood pressure at the lower doses is similar
to the effects observed by Mugabo et al. and Ojewole in anaes-
thetized normotensive animals using crude aqueous extracts of
the plant,5,6 while the increase in blood pressure at higher doses
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(3.0–5.0 mg kg–1) was similar to that noted in earlier experiments
using crude aqueous extracts of the leaves only.8 The effect on
HR was similar to that observed by Obikeze et al. and Ojewole
with the crude aqueous extract, but was opposite to the increase
in HR observed by Obikeze et al. with methanol fractions of the
leaves.5,7,8 The differences in the effects observed by the different
researchers with the plant may be explained by the likely presence
of more than one cardio-active compound in the crude plant
extracts. Diterpenoids isolated from other plants have also
been shown to exhibit varying effects on the cardiovascular
system.16,17 Most diterpenoids assayed for cardiovascular activity
seem to have singular effects, and those that have been shown to
exhibit bi-phasic effects are thought to do so mainly via baro-
receptor reflex mechanisms in the animals.18,19 The decrease in
blood pressure observed at the low doses of diterpenoid 1 may
be due to vasodilation, which has been reported with the crude
aqueous extract and with many diterpenes assayed for cardio-
vascular activity.5,16,20 Activation of the baroreceptor reflex
mechanism may explain the observed increase in BP at the
higher doses of diterpenoid 1. A similar scenario involving
the activation of the baroreceptor reflex has been reported in
anaesthetized rats administered with a labdenic diterpene
Labd-8 (17)-en-15-oic acid by Lahlou and co-workers.18
Diterpenoid 1 exhibited a negative chronotropic effect on the
heart, and diterpenoids have been shown to exhibit different
effects on heart rate through the mechanisms of calcium channel
antagonism, adenylate cyclase activation, Na+/K+ channel
blockade and the release of nitric oxide.16,19–21 Our results suggest
that the cardiovascular effects of diterpenoid 1 are mediated
either by the blockade of β1 receptors in the heart, or the inhibi-
tion of Ca2+, Na+ and/or K+ channels in the heart. Further studies
are, however, required to elucidate the exact mechanism of
action of diterpenoid 1.
3. Experimental
Optical rotations were measured with a Bellingham & Stanley
ADP 220 polarimeter (Tunbridge Wells, England). IR spectra
were obtained using a Perkin-Elmer Paragon 1000 PC (Waltham,
MA, USA). 1H, 13C, 1H-1H COSY, HSQC, HMBC, DEPT and
NOESY NMR spectra were collected on a Varian UnityInova 600
NMR spectrometer (Palo Alto, CA, USA) at 25 °C. 1H and 13C
NMR spectra were referenced to TMS. The high-resolution ESI
mass spectrum was obtained on a Waters API X-TOF Ultima
(Milford, MA, USA) instrument.
The stems and leaves of L. leonurus were collected from
Montague Botanic Gardens, Cape Town, South Africa, and a
voucher specimen (No. 6859) deposited at the herbarium of the
Department of Botany, University of the Western Cape. Fresh
leaves of the plant were washed, dried at 30 °C in a ventilated
oven for 72 h, and then ground into fine powder of which 83 g
was heated in methanol (3 L) under reflux for 24 h and then
filtered. Excess solvent was removed in vacuo to afford a thick
residue. Distilled water (1 L) was added to the residue and the
solution was acidified using concentrated HCl. This acidified
solution was extracted with chloroform (2 × 250 mL), and then
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Figure 1 Structure and 1H NMR spectrum of (13S)-9α,13α-epoxylabda-6β(19),15(14)diol dilactone (1).
Figure 2 NOE correlations observed for compound 1.
basified with concentrated ammonia. The basified solution was
in turn extracted using ethyl acetate (2 × 250 mL) and chloroform
(2 × 250 mL). TLC was used to determine similar compounds in
the two extracts which were combined, dried with anhydrous
magnesium sulphate and evaporated. Chromatography of these
residues was carried out on a silica gel (70–230 mesh grade)
column, using ethyl acetate:hexane (1:4) as eluent. Further
chromatographic purification on silica gel was carried out on the
major fraction obtained using ethyl acetate:hexane:acetic acid
as eluent (3:2:1 initially and then 3:2:0.5; and finally 3:1:0.5).
Crystallization from chloroform yielded the pure diterpenoid 1
(1.526 g).
(13S)-9,13-epoxylabda-6(19),15(14)diol dilactone (1): colour-
less needles (CHCl3); m.p. 162.9–164.2 °C; [α]
19
D +14.1 (c 0.78,
CHCl3); IR (Nujol) νmax 2909, 1770, 1462, 1374, 1196, 1100, 994 and
911 cm–1; 1H NMR (CDCl3, 600 MHz) δ 4.70 (1H, dd, J = 4.6, 5.7 Hz,
H-6), 4.38 (1H, ddd, J = 6.0, 7.2, 9.0 Hz, H-15a), 4.20 (1H, ddd, J =
6.3, 7.2, 9.0 Hz, H-15b), 2.46 (1H, ddd, J = 6.3, 7.2, 13.3 Hz, H-16a),
2.27 (3H, m, H-11a, H-12a, H-16b) , 2.17 (3H, m H-5, H-7eq, H-8),
2.09 (3H, m, H-1eq, H-3eq, H-12b), 1.90 (1H, ddd, J = 4.2, 12.2,
18.3 Hz, H-11b), 1.73 (1H, m, H-2eq), 1.65 (1H, m, H-7ax), 1.56
(1H, m, H-2ax), 1.45 (1H, dt, J = 5.1, 14.4 Hz, H-3ax), 1.28 (3H, s,
H-18), 1.19 (1H, dt, J = 8.2, 13.2 Hz, H-1ax), 1.05 (3H, s, H-20) and
0.91 ppm (3H, d, J = 6.1 Hz, H-17); 13C NMR (CDCl3, 150 MHz)
δ 183.8 (C, C-19), 171.4 (C, C-14), 93.5 (C, C-9), 83.6 (C, C-13), 76.1
(CH, C-6), 65.0 (CH2, C-15), 45.8 (CH, C-5), 44.1 (C, C-4), 39.3 (C,
C-10), 37.3 (CH2, C-16), 34.3 (CH2, C-12), 32.2 (CH2, C-7), 31.5 (CH,
C-8), 29.3 (CH2, C-11), 28.3 (CH2, C-3), 27.8 (CH2, C-1), 23.8 (CH3,
C-20), 23.1 (CH3, C-18), 17.9 (CH2, C-2) and 17.5 ppm (CH3, C-17);
HRESIMS pos. m/z 349.2009 [M + H]+ (calcd. for C20H29O5
349.2015).
The anaesthetized normotensive rat model was used to
determine in vivo cardiovascular activity.22 Normotensive male
Wistar rats, 250–400 g, 3–4 months old, were anaesthetized using
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Figure 3 Effect of diterpenoid 1 on blood pressures (SP, DP, MAP) in anaesthetized normotensive rats.
Figure 4 Effect of diterpenoid 1 on heart rate (HR) in anaesthetized normotensive rats.
sodium pentobarbital (30 mg kg–1 I.P). Anaesthetized rats were
tracheotomized to facilitate breathing and the external jugular
vein and the femoral artery cannulated for the infusion of drug
substances and for the measurement of blood pressure and heart
rate respectively. Blood pressure and heart rate were monitored
continuously throughout the experiment through a blood
pressure transducer linking the arterial cannula to a PowerLab
T20 (AD Instruments, Sydney, Australia) via a blood pressure
amplifier (AD Instruments). Blood pressure readings measured
as systolic pressure (SP), diastolic pressure (DP) and mean
arterial pressure (MAP), and heart rate (HR) readings were
recorded using the Chart 4.0 software (AD Instruments) run-
ning on a computer connected to the PowerLab T20. Random-
ized doses of the isolated compound (0.5, 1.0, 2.0, 3.0, 4.0 and
5.0 mg kg–1) were administered. Time intervals between succes-
sive injections were such as to allow for the return of blood pres-
sure and heart rate to baseline values.
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